| Patents for B82Y 5 - Nano-biotechnology or nano-medicine, e.g. protein engineering or drug delivery (2,162) |
|---|
| 10/06/2011 | US20110245460 Solvent resistant diafiltration of peptides, pna or oligonucleotides |
| 10/06/2011 | US20110244571 Cell growth |
| 10/06/2011 | US20110244056 Multifunctional silica-based compositions and gels, methods of making them, and methods of using them |
| 10/06/2011 | US20110244048 Multifunctional self-assembling polymeric nanosystems |
| 10/06/2011 | US20110244025 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity |
| 10/06/2011 | US20110244024 Microrna compositions and methods for the treatment of myelogenous leukemia |
| 10/06/2011 | US20110244011 Specific delivery of agrochemicals |
| 10/06/2011 | US20110244001 System and method for the release of nitric oxide using nanoscale media |
| 10/05/2011 | EP2371365A1 Compositions comprising an epothilone and production methods |
| 09/29/2011 | WO2011119654A1 Ligands for semiconductor nanocrystals |
| 09/29/2011 | WO2011119128A1 Ultra-pure aqueous solution of a metal carboxylate |
| 09/29/2011 | WO2011070212A3 Multifunctional nanostructures as trimodal mri/oi/spect diagnosis agents |
| 09/29/2011 | WO2011070203A3 Multifunctional vectorised nanostructures that can be used as trimodal (mri, oi and spect) diagnosis agents |
| 09/29/2011 | US20110238075 Drug delivery devices and methods |
| 09/29/2011 | US20110237862 MULTIFUNCTIONAL Fe3O4 CORED MAGNETIC-QUANTUM DOT FLUORESCENT NANOCOMPOSITES FOR RF NANO-HYPERTHERMIA OF CANCER CELLS |
| 09/29/2011 | US20110237686 Formulations and methods of use |
| 09/29/2011 | US20110237536 Treating or Preventing Pain Using Spicamycin Derivatives |
| 09/29/2011 | US20110236984 Dna sequencing methods and detectors and systems for carrying out the same |
| 09/29/2011 | US20110236974 Compositions and methods for making and using laminin nanofibers |
| 09/29/2011 | US20110236957 Nanoparticle Labeling Reagents and Methods of Use |
| 09/29/2011 | US20110236724 Device and method for performing a biologically catalyzed electrochemical reaction |
| 09/29/2011 | US20110236487 Solid ganaxolone formulations and methods for the making and use thereof |
| 09/29/2011 | US20110236472 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 09/29/2011 | US20110236441 Antimicrobial substrates and uses thereof |
| 09/29/2011 | US20110236437 Nanoparticles and methods of use |
| 09/29/2011 | US20110236430 Method for controlling toxicity of metallic particle and low-toxicity composite of metallic nanoparticle and inorganic clay |
| 09/29/2011 | US20110236309 Antagonists of ligands and uses thereof |
| 09/29/2011 | US20110233427 Magnetite-silver heterodimer nanoparticles and their preparation and use for two-photon fluorescence |
| 09/29/2011 | US20110233169 Titanium nano-scale etching on an implant surface |
| 09/28/2011 | EP2367946A1 Genetic material processing and manipulation methods |
| 09/28/2011 | EP2367425A1 Combinations and modes of administration of therapeutic agents and combination therapy |
| 09/28/2011 | EP2033934B1 Hollow-fiber-like organic nanotube and process for production thereof |
| 09/22/2011 | WO2011113616A1 A nanoparticle comprising a micelle formed by an amphiphilic block- copolymer and encapsulating a gadolinium complex |
| 09/22/2011 | US20110230427 Materials and methods for stabilizing nanoparticles in salt solutions |
| 09/22/2011 | US20110229970 Dual-chamber perfusion bioreactor for orthopedic tissue interfaces and methods of use |
| 09/22/2011 | US20110229589 Insect and plant disease control compositions and methods of use thereof |
| 09/22/2011 | US20110229581 Releasable cationic lipids for nucleic acids delivery systems |
| 09/22/2011 | US20110229579 Support Having Nanostructured Titanium Dioxide Film And Uses Thereof |
| 09/22/2011 | US20110229577 Biologically active silicic acid |
| 09/22/2011 | US20110229559 Drug Release From Nanoparticle-Coated Capsules |
| 09/22/2011 | US20110229556 Lipid-coated polymer particles for immune stimulation |
| 09/22/2011 | US20110229554 INTRAVENOUS FORMULATIONS OF COENZYME Q10 (CoQ10) AND METHODS OF USE THEREOF |
| 09/22/2011 | US20110229550 Acid-Degradable and Bioerodible Modified Polyhydroxylated Materials |
| 09/22/2011 | US20110229545 Melt emulsification |
| 09/22/2011 | US20110229532 Process for nanoemulsification of curcumin and derivatives of curcumin |
| 09/22/2011 | US20110229416 Amphiphilic macromolecules for solubilizing nanocrystals |
| 09/15/2011 | US20110224723 Cyanoacrylate tissue adhesives |
| 09/15/2011 | US20110224675 Minimally invasive treatment of vertebra (mitv) using a calcium phosphate combination bone cement |
| 09/15/2011 | US20110223666 Cytoplasm exposure additive and method for exposing particles delivered into cell to cytoplasm from endocytic vesicles in intact cell |
| 09/15/2011 | US20110223314 Efficient microencapsulation |
| 09/15/2011 | US20110223257 Releasable fusogenic lipids for nucleic acids delivery systems |
| 09/15/2011 | US20110223255 Implantable products comprising nanoparticles |
| 09/15/2011 | US20110223240 Compounds for reversing and inhibiting protein aggregation, and methods for making and using them |
| 09/15/2011 | US20110223216 Nanoparticles and Porous Particles and Methods of Making the Same |
| 09/15/2011 | US20110223202 Cationic core-shell peptide nonoparticles |
| 09/09/2011 | WO2011107822A1 High surface area fibrous silica nanoparticles |
| 09/08/2011 | US20110218616 Cancer Stent Treatment Device Using Nanotechnology |
| 09/08/2011 | US20110218380 Magnetic nanoparticle and group of nanoparticles |
| 09/08/2011 | US20110218140 Biodegradable therapeutic nanoparticles containing an antimicrobial agent |
| 09/08/2011 | US20110217553 Frozen Ionic Liquid Microparticles and Nanoparticles, and Methods for their Synthesis and Use |
| 09/08/2011 | US20110217379 Magnetic nanomaterials and methods for chemoembolisation |
| 09/08/2011 | US20110217377 Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents |
| 09/08/2011 | US20110217365 Compositions and Methods for Gene Silencing |
| 09/08/2011 | US20110217357 Method for solubilizing metronidazole |
| 09/08/2011 | US20110215002 Sensing device and related methods |
| 09/08/2011 | DE102011004987A1 Magnetischer Nanopartikel und Gruppe von Nanopartikeln Magnetic nanoparticles and nanoparticle group |
| 09/07/2011 | CN102174239A Polymethyl methacrylate with micro-nano topological structure and preparation method and application thereof |
| 09/01/2011 | WO2011106459A2 Analyte sequencing with nanopores |
| 09/01/2011 | WO2011104497A1 Method for the preparation of a novel nanoparticle conjugate |
| 09/01/2011 | US20110213193 Magnetic Nanodelivery of Therapeutic Agents Across the Blood Brain Barrier |
| 09/01/2011 | US20110213121 Nanoparticle sensor for measuring protease activity and method for manufacturing the same |
| 09/01/2011 | US20110212187 Antimicrobial composition |
| 09/01/2011 | US20110212157 Dermal delivery |
| 09/01/2011 | US20110212145 Hair fixatives comprising cross linked starches |
| 09/01/2011 | US20110212142 Curcuminoids and its metabolites for the application in ocular diseases |
| 09/01/2011 | US20110212029 Detection of cancer |
| 09/01/2011 | DE10320604B4 Partikel umfassend ein Biopolymer, das unter Einwirkung von elektromagnetischen Wellen, ausgestrahlt durch Sonneneinstrahlung, abbaubar ist Particles comprising a biopolymer that is under the influence of electromagnetic waves emitted by the sun, degradable |
| 09/01/2011 | CA2790666A1 Analyte sequencing with nanopores |
| 08/25/2011 | US20110207685 Oral Formulations of Chemotherapeutic Agents |
| 08/25/2011 | US20110206772 Polysaccharide composition and methods of isolation of the emulsion stabilizing cationic polyelectrolytic polysaccharide |
| 08/25/2011 | US20110206760 Angiopoietin derived peptides |
| 08/25/2011 | US20110206753 Nanoparticulate copper compounds |
| 08/25/2011 | US20110206618 Fluorescent labeling material and flourescent labeling agent |
| 08/25/2011 | US20110206617 Modified polysaccharides for drug and contrast agent delivery |
| 08/25/2011 | US20110206611 DNA Dendrimers as Thermal Ablation Devices |
| 08/24/2011 | EP2359859A1 Compositions comprising albumin nanoparticles and methods of delivery of pharmacological agents |
| 08/18/2011 | US20110203013 Delivering compositions of interest to plant cells |
| 08/18/2011 | US20110201994 Methods to regulate polarization of excitable cells |
| 08/18/2011 | US20110201680 formulation of silymarin with high efficacy and prolonged action and the preparation method thereof |
| 08/18/2011 | US20110200677 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer |
| 08/18/2011 | US20110200657 Methods of using nanoemulsion compositions having anti-inflammatory activity |
| 08/18/2011 | US20110200581 Pharmaceutical compositions |
| 08/18/2011 | US20110200536 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 08/18/2011 | US20110200534 T1-T2 Dual Modal MRI Contrast Agents |
| 08/17/2011 | CN102154436A Cell recognition and detection method based on biochemical reagent of supermolecule nanometer self-assembled system |
| 08/17/2011 | CN102154352A Cationized polysaccharide nanoparticle gene delivery systems and manufacturing method thereof |
| 08/17/2011 | CN102154351A Cationic angelica polysaccharide nanoparticle gene delivery system and preparation method thereof |
| 08/17/2011 | CN102154350A Nanoparticle gene delivery system of cationized lycium barbarum polysaccharides and preparation method thereof |
| 08/17/2011 | CN102154349A Cationized mulberry polysaccharide nanoparticle gene vectors and manufacturing method thereof |
| 08/11/2011 | US20110195456 Methods and compositions for the production of monoclonal antibodies |